文章基本信息

标题：Methylxanthines and Neurodegenerative Diseases: An Update
本地全文：下载
作者：Daniel Janitschke ; Anna A. Lauer ; Cornel M. Bachmann 等
期刊名称：Nutrients
电子版ISSN：2072-6643
出版年度：2021
卷号：13
期号：3
页码：803
DOI：10.3390/nu13030803
出版社：MDPI Publishing
摘要：Methylxanthines (MTX) are purine derived xanthine derivatives. Whereas naturally occurring methylxanthines like caffeine, theophylline or theobromine are widely consumed in food, several synthetic but also non-synthetic methylxanthines are used as pharmaceuticals, in particular in treating airway constrictions. Besides the well-established bronchoprotective effects, methylxanthines are also known to have anti-inflammatory and anti-oxidative properties, mediate changes in lipid homeostasis and have neuroprotective effects. Known molecular mechanisms include adenosine receptor antagonism, phosphodiesterase inhibition, effects on the cholinergic system, wnt signaling, histone deacetylase activation and gene regulation. By affecting several pathways associated with neurodegenerative diseases via different pleiotropic mechanisms and due to its moderate side effects, intake of methylxanthines have been suggested to be an interesting approach in dealing with neurodegeneration. Especially in the past years, the impact of methylxanthines in neurodegenerative diseases has been extensively studied and several new aspects have been elucidated. In this review we summarize the findings of methylxanthines linked to Alzheimer´s disease, Parkinson’s disease and Multiple Sclerosis since 2017, focusing on epidemiological and clinical studies and addressing the underlying molecular mechanisms in cell culture experiments and animal studies in order to assess the neuroprotective potential of methylxanthines in these diseases.
关键词：methylxanthines; caffeine; theobromine; theophylline; pentoxifylline; propentofylline; istradefylline; Alzheimer´s disease; Parkinson´s disease; Multiple Sclerosis methylxanthines ; caffeine ; theobromine ; theophylline ; pentoxifylline ; propentofylline ; istradefylline ; Alzheimer´s disease ; Parkinson´s disease ; Multiple Sclerosis